RecruitingPhase 3NCT07062965
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Sponsor: Pfizer
City of Saint Peters, MO · Columbia, MO · Creve Coeur, MO · +212 more sites